Collaborating within the European Infect-Met consortium, the JRC has validated novel digital PCR detection methods for the bacterium causing Tuberculosis. These methods allow for the evaluation of the performance and control of the quality of quantitative DNA-based methods. Therefore, they have the potential to improve Tuberculosis treatment.
Further information: Can novel digital PCR methods improve tuberculosis patient care?